FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sandoz Bimatoprost Ophthalmic Solution 0 Recall

Bimatoprost Ophthalmic Solution 0

Sandoz Inc · Princeton, NJ

Risk level
Class III
Reported by FDA
Nov 6, 2019
Recall ID
D-0161-2020
Check your lot numberHow we source this data

Summary

Sandoz recalled Bimatoprost Ophthalmic Solution 0 starting Oct 17, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0161-2020 on Nov 6, 2019. Reason: Labeling: Incorrect or missing package insert. Status: Terminated.

Why it was recalled

Labeling: Incorrect or missing package insert.

Product description

Bimatoprost Ophthalmic Solution 0.03%, Rx Only, For Topical Application to the Upper Eyelid, Sterile, a) 3 mL bottle NDC 0781-6206-93, b) 5 mL bottle NDC 0781-6206-75, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc., Princeton, NJ 08540, Product of Argentina.

Lot numbers, UPCs & expiration codes

Lot #s: a) 290635FA, 290635FB, Exp. 11/30/2019; 293230F, Exp. 6/30/2020; 294628F, 301337F, Exp. 11/30/2020; 304451FA, Exp. 1/31/2021. b) 290636FA, 290636FB, 290636FC, Exp. 11/30/2019; 293233FA, 293233FB, Exp. 5/31/2020; 293234FA, 293234FB, Exp. 6/30/2020; 294630F, 301338FA, 301338FB, 309426F, Exp. 11/30/2020; 304455FA, 304455FB Exp. 2/28/2021; 304883F, Exp. 4/30/2021; 312790F, Exp. 5/31/2021.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0161-2020
Classification
Class III
Status
Terminated
Recall initiated
Oct 17, 2019
FDA report date
Nov 6, 2019
Quantity
346,929 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Inc

Original FDA data

Every field from FDA enforcement report D-0161-2020, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
84082
Address
100 College Rd W
Code information
Lot #s: a) 290635FA, 290635FB, Exp. 11/30/2019; 293230F, Exp. 6/30/2020; 294628F, 301337F, Exp. 11/30/2020; 304451FA, Exp. 1/31/2021. b) 290636FA, 290636FB, 290636FC, Exp. 11/30/2019; 293233FA, 293233FB, Exp. 5/31/2020; 293234FA, 293234FB, Exp. 6/30/2020; 294630F, 301338FA, 301338FB, 309426F, Exp. 11/30/2020; 304455FA, 304455FB Exp. 2/28/2021; 304883F, Exp. 4/30/2021; 312790F, Exp. 5/31/2021.
Postal code
08540-6604
Report date
Nov 6, 2019
Product type
Drugs
Recall number
D-0161-2020
Classification
Class III
Recalling firm
Sandoz Inc
Product quantity
346,929 bottles
Termination date
Jan 19, 2022
Reason for recall
Labeling: Incorrect or missing package insert.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bimatoprost Ophthalmic Solution 0.03%, Rx Only, For Topical Application to the Upper Eyelid, Sterile, a) 3 mL bottle NDC 0781-6206-93, b) 5 mL bottle NDC 0781-6206-75, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc., Princeton, NJ 08540, Product of Argentina.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Oct 17, 2019
Initial firm notification
Letter
Center classification date
Oct 28, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0161-2020, published Nov 6, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls